drop from 10 to 9 rm
Big boys are selling for now.
so wait and see.

Omicron is no issue already for now. unless death rate shoots up.
All world economy is opening .
but with inflation and interest rate possible up... its a sell off for now.

EPF/IB selling blue chip stocks heavily cos they know the economy will be going bad. my observations.

Good ... Another wake up call for factories/manufacturers to stop exploit of workers.
Boss always exploit worker ...cos more profits.
our NGO are sleeping .
Authorities all sleeping . or our standards so low ?
all come down to Cash is King in Msia.

Why this EPF keep selling many other blue chips and not buyin much . Is there some thing we dont know..?? this has been a trend for a few weeks now .

This SD will be suspended till Kingdom come . Avoid all as High Risk .

Last trading day.. tomorrow kena bungkus .

if 2022 economy predicted at 5 % why Banks you downgrade ??

This can cause long term effects with chronic diseases .
Those concern about the risk will stop eatin for sure. or eat less.

So just how serious is acrylamide exposure?
In 2005, the UN Food and Agriculture Organization (FAO) and the World Health Organization (WHO) warned that acrylamide in foods may be of public health concern and further noted that acrylamide “may be responsible for up to one third of all cancers cause by diet”.

Acrylamide: A Triple Threat To Your Health
Researchers believe acrylamide causes damage in three ways:

It reduces the body’s production of phase 2 enzymes which detoxify toxins and disarm carcinogens. This includes glutathione, your body’s most important antioxidant and detoxifier.
Acrylamide also affects the endocrine system, altering your delicate balance of hormones. Over time this can lead to cellular mutations and dysfunction.
It acts as a genotoxic, neurotoxic and cytotoxic agent, directly damaging genes, neurons and cells.

the bet is GST will come back soon . Buy !

Putrajaya extends CMCO in five states and KL as it warns of possible fourth infection wave

political issue uncertainly. no end this ..
many stocks overprice. latest earning s are not impressive.
look at yesterday trade ... local IB dump BIG .
only retails are buying possible to goreng .

Msia send/sell vegi , eggs also kena ban from SIngapore .
just follow the rules if you want your exports to go thru.
dont need to play the blame game.

remember msia also ban steel products ..but you say nothing ..

bet to start sell NOW.. you know the play style .

heavy funds buying today. maybe $ from gloves.
monitor and buy for Long term .

long term investors will sell down
goreng kaki will hit & run when time is right.

by end of the year covid will be controlled .
no more growth right ?
no reason to buy for investment .

yaa.... last 4 months drop nearly 50 % already .
gloves hype is over for now.
money is going into recovery stocks..

mean s better run fast .

yaa this 8888 is the fake one !

experts say buy cos cheap .
BUT look at the RSS volumes today.... better run fast !

Fitch Ratings said in a report today, rating outlooks had turned negative for banks in most jurisdictions this year compared to 2020.

In its "2021 Global Banks' Outlook Compendium", the rating agency said this reflects downside risks to its baseline scenario from a potentially sluggish economic recovery following sharp deterioration in 2020 owing to the pandemic.

Fitch said the rating outlook for Malaysian banks was “negative”, while the sector outlook was “stable”.

It said the key issues for Malaysian banks were slow non-performing loan recognition, lower profitability and property market risks.

Fitch Ratings said in a report today, rating outlooks had turned negative for banks in most jurisdictions this year compared to 2020.

In its "2021 Global Banks' Outlook Compendium", the rating agency said this reflects downside risks to its baseline scenario from a potentially sluggish economic recovery following sharp deterioration in 2020 owing to the pandemic.

Fitch said the rating outlook for Malaysian banks was “negative”, while the sector outlook was “stable”.

It said the key issues for Malaysian banks were slow non-performing loan recognition, lower profitability and property market risks.

yes...for now HSR is total cancelled . as said in the news.

from news.
A multi-billion-dollar high-speed rail link between Singapore and Malaysia’s capital Kuala Lumpur has been terminated.

Singapore local transmission this week average near 5 cases.
compare with KL City .... 200 !

from google.
NO NEW CASES OF LOCALLY TRANSMITTED COVID-19 INFECTION
3RD JAN 2021
As of 3 January 2021, 12pm, the Ministry of Health (MOH) has preliminarily confirmed that there are no new cases of locally transmitted COVID-19 infection.

yes... BUT what he say is correct...

i think the foxconn deal will be better . better company with great management and focus. and i trust a taiwan co better than the china one.
DNex is a joke . lookin at the share price history you can tell . they survive due to handouts . what have they done that is great ?
typical of malaysian co.. like MAS, jaring , Mimos , all failed co.

meanwhile try to profit from this speculation .

yes.... for sure next year will be above 5 .

for sure there will be huge demand from countries all over.
who ever can commit early delivery get the contract ya.
Think about that .

if CPO price too high they will go buy some other Oil lah .

PM @MuhyiddinYassin has also announced that the COVID-19 vaccine that the government procures will be FREE for Malaysians. The first shipment of Pfizer vaccines of 1mn doses will arrive in Q1 2021. This will be used to vaccinate 500k frontline workers first. Then we will prioritise high risk groups (elderly, those with comorbidity), followed by general population.

this is a up trending stock just hold.
and buy more if it corrects .

With this MOU, Kanger will collaborate with ZP to facilitate the import, warehousing, and distribution of Covid-19 vaccines in Malaysia. Sinopharm

so how is Dpharma involve ? How much profit can they make ?

i dont see how Douph will be in covid vaccine . what contract so far ?
speculate only for now.

Local institutional investors – net buyers – raising exposure to Covid-19 recovery plays
 Local institutional investors raised their net buy flows by 34% wow last week as they continued to trade on the potential winners of the
Covid-19 vaccine discovery.
 Local institutional investors were buyers of Public Bank (RM215m), Genting (RM128m) and CIMB (RM120m) last week, while their key
net sells were Kossan (-RM146m), Supermax (-RM144m) and Top Glove (-RM74m).
source CIMB .

there are about 5 to 10 vaccines that will be available early 2021 .
just select the ones with good test results .
from china there are at least 3 vaccines.

now all will cheer vaccine and recovery stocks.
more money is moving out of gloves...
just look at the signs bro...

yes ...market is looking 6 months ahead.
check report today ASP prices are dropping .
blue chips are moving.........

The Recover theme is getting stronger by the day..
majority will move their money there .
imagine Genting up 20% this few days !

CanSino Biologics
Name: Ad5-nCoV

Who: A Chinese biopharmaceutical company.

What: CanSino has also developed a viral vector vaccine, using a weakened version of the adenovirus as a vehicle for introducing the SARS-CoV-2 spike protein to the body. Preliminary results from phase two trials, published in The Lancet, have shown that the vaccine produces “significant immune responses in the majority of recipients after a single immunisation.” There were no serious adverse reactions documented.

Status: Though the company was still technically in phase two of its trial, on June 25, CanSino became the first company to receive limited approval to use its vaccine in people. The Chinese government has approved the vaccine for military use only, for a period of one year. On August 15, Russian biopharmaceutical company Petrovax announced it had launched the first phase three clinical trial of Ad5-nCoV.

from google.

Sinopharm

Who: China’s state-run pharmaceutical company, in collaboration with the Wuhan Institute of Biological Products.

What: Sinopharm is also using an inactivated SARS-CoV-2 vaccine that it hopes will reach the public by the end of 2020. Preliminary findings from two randomized trials, published in JAMA, have shown the vaccine can trigger an antibody response with no serious adverse effects. The study did not measure T cell-mediated immune responses. These results are significant, though, as they are the first published data from human clinical trials for a COVID-19 vaccine that uses a whole, inactivated virus.

Status: On September 29, the New Yorker reported that Sinoparm is filing its application to China’s regulatory commission for approval of the vaccine, which could arrive sometime in October. The story also notes that hundreds of thousands of Chinese civilians have already been vaccinated under the government’s emergency-use approval. China began to innoculate medical workers and other high-risk groups with the Sinopharm trial vaccines in July, making it the first experimental vaccine available to civilians beyond clinical volunteers. Also in July, Sinopharm launched its first phase three trial among 15,000 volunteers—aged 18 to 60, with no serious underlying conditions—in the United Arab Emirates. The company selected the UAE because it has a diverse population made up of approximately 200 nationalities, making it an ideal testing ground. Sinopharm will also undertake phase three trials in locations such as Peru and Bahrain.

In a note this morning, AmInvestment Bank Research reiterated its view that the market will continue to shift to predominantly pandemic-themed plays to a recovery-focused theme in December.

“We have been advocating for investors to lighten their positions in the 'pandemic play', i.e. glove stocks, and replace them with the 'recovery play'.

mplus was unstable but still can trade .

Post removed.Why?

check the report lah...they have been selling !

if this Q make loss .. all will get burn .

it went up like 30 % on expectation of strong profits .
today release profits is weak .
the smart will dump this slowly .

overvalue ! sell and run fast
78M profit.... joke lah .

wait gloves tax coming soon .

Maybank Investment Bank Research said the supernormal profits being generated by the gloves sector and the government’s extremely challenging fiscal outlook raises the risk of windfall taxes being imposed on the gloves sector.

“The imposition of windfall taxes is not without precedent, being most recently raised by the government in 2008. In fact, there is a specific legal act governing windfall tax application per the Windfall Profit Levy Act 1998, which allows the Minister of Finance to submit a levy order to Parliament for approval within 120 days, ” it said.

i see no reason to buy if above 1 RM.
all speculation with no profit figures ...
just goreng then run away fast !

yes SELL
with 3rd wave virus now around the world.
with CMCO in msia and other countries.
its not looking good .